Publications

  1. Corral JE, Hoogenboom SA, Kroner PT, Vazquez-Roque MI, Picco MF, Farraye FA, Wallace MB. COVID-19 polymerase chain reaction testing before endoscopy: an economic analysis. Gastrointest Endosc. 2020 Sep; 92 (3):524-534.e6 Epub 2020 Apr 28
    View PubMed
  2. Wang MH, Mousa OY, Friton JJ, Raffals LE, Leighton JA, Pasha SF, Picco MF, Cushing KC, Monroe K, Nix BD, Newberry RD, Faubion WA. Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US Experience. Inflamm Bowel Dis. 2020 Apr 11; 26 (5):774-779
    View PubMed
  3. Limdi JK, Picco M, Farraye FA. A review of endoscopic scoring systems and their importance in a treat-to-target approach in inflammatory bowel disease (with videos). Gastrointest Endosc. 2020 Apr; 91 (4):733-745 Epub 2019 Nov 29
    View PubMed
  4. Labarca G, Drake L, Horta G, Jantz MA, Mehta HJ, Fernandez-Bussy S, Folch E, Majid A, Picco M. Association between inflammatory bowel disease and chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMC Pulm Med. 2019 Oct 28; 19 (1):186
    View PubMed
  5. Wang , Mousa OY, Friton JJ, Raffals LE, Leighton JA, Pasha SF, Picco MF, Cushing KC, Monroe K, Nix BD, Newberry RD, Faubion WA. Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Inflamm Bowel Dis. 2019.
  6. Picco MF, Farraye FA. Targeting Mucosal Healing in Crohn's Disease. Gastroenterol Hepatol (N Y). 2019 Oct; 15 (10):529-538
    View PubMed
  7. Wang MH, Friton JJ, Raffals LE, Leighton JA, Pasha SF, Picco MF, Cushing KC, Monroe K, Nix BD, Newberry RD, Faubion WA. Novel Genetic Risk Variants Can Predict Anti-TNF Agent Response in Patients With Inflammatory Bowel Disease. J Crohns Colitis. 2019 Aug 14; 13 (8):1036-1043
    View PubMed
  8. Picco MF. Is autofluorescence inferior to chromoendoscopy for dysplasia detection in ulcerative colitis? Lancet Gastroenterol Hepatol 2018 May; 3 (5):290-291 Epub 2018 Mar 20
    View PubMed
  9. Wang MH, Picco MF. Crohn's Disease: Genetics Update. Gastroenterol Clin North Am. 2017 Sep; 46 (3):449-461 Epub 2017 July 19
    View PubMed
  10. Sanduleanu S, Kaltenbach T, Barkun A, McCabe RP, Velayos F, Picco MF, Laine L, Soetikno R, McQuaid KR. A roadmap to the implementation of chromoendoscopy in inflammatory bowel disease colonoscopy surveillance practice. Gastrointest Endosc. 2016 Jan; 83: (1)213-22.
    View PubMed
  11. Wang YR, Cangemi JR, Loftus EV Jr, Picco MF. Decreased Risk of Colorectal Cancer after Colonoscopy in Patients 76-85 Years Old in the United States. Digestion. 2016; 93: (2)132-8.
    View PubMed
  12. Bartel MJ, Picco MF, Wallace MB. Chromocolonoscopy. Gastrointest Endosc Clin N Am. 2015 Apr; 25: (2)243-60.
    View PubMed
  13. Picco MF. The changing approach to Colorectal cancer surveillance in Ulcerative Colitis Northeast Florida Medical Journal .2015;66:32-36.
  14. Wallace MB, Crook JE, Coe S, Ussui V, Staggs E, Almansa C, Patel MK, Bouras E, Cangemi J, Keaveny A, Picco M, Riegert-Johnson D. Accuracy of in vivo colorectal polyp discrimination by using dual-focus high-definition narrow-band imaging colonoscopy. Gastrointest Endosc. 2014 Dec; 80(6):1072-87. Epub 2014 Jun 25.
    View PubMed
  15. Leong RW, Butcher RO, Picco MF. Implementation of image-enhanced endoscopy into solo and group practices for dysplasia detection in Crohn's disease and ulcerative colitis. Gastrointest Endosc Clin N Am. 2014 Jul; 24(3):419-25.
    View PubMed
  16. Wang YR, Cangemi JR, Loftus EV Jr, Picco MF. Use of surveillance colonoscopy in medicare patients with inflammatory bowel disease prior to colorectal cancer diagnosis. Digestion. 2014; 90(1):58-62. Epub 2014 Sep 02.
    View PubMed
  17. Picco MF, Pasha S, Leighton JA, Bruining D, Loftus EV Jr, Thomas CS, Crook JE, Krishna M, Wallace M. Procedure time and the determination of polypoid abnormalities with experience: implementation of a chromoendoscopy program for surveillance colonoscopy for ulcerative colitis. Inflamm Bowel Dis. 2013 Aug; 19 (9):1913-20
    View PubMed
  18. Wang YR, Cangemi JR, Loftus EV Jr, Picco MF. Increased odds of interval left-sided colorectal cancer after flexible sigmoidoscopy compared with colonoscopy in older patients in the United States: a population-based analysis of the SEER-Medicare linked database, 2001-2005. Mayo Clin Proc. 2013 May; 88(5):471-8. Epub 2013 Apr 04.
    View PubMed
  19. Wang YR, Cangemi JR, Loftus EV Jr, Picco MF. Risk of colorectal cancer after colonoscopy compared with flexible sigmoidoscopy or no lower endoscopy among older patients in the United States, 1998-2005. Mayo Clin Proc. 2013 May; 88(5):464-70. Epub 2013 Mar 21.
    View PubMed
  20. Wang YR, Cangemi JR, Loftus EV Jr, Picco MF. Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States. Am J Gastroenterol. 2013 Mar; 108(3):444-9. Epub 2013 Jan 08.
    View PubMed
  21. Wang YR, Loftus EV Jr, Cangemi JR, Picco MF. Racial/Ethnic and regional differences in the prevalence of inflammatory bowel disease in the United States. Digestion. 2013; 88(1):20-5. Epub 2013 Jun 22
    View PubMed
  22. Gross SA, Buchner AM, Crook JE, Cangemi JR, Picco MF, Wolfsen HC, DeVault KR, Loeb DS, Raimondo M, Woodward TA, Wallace MB. A comparison of high definition-image enhanced colonoscopy and standard white-light colonoscopy for colorectal polyp detection. Endoscopy. 2011 Dec; 43: (12)1045-51.
    View PubMed
  23. Wang YR, Talley NJ, Picco MF. Overlap irritable bowel syndrome, inflammatory bowel disease, and diverticular disease. J Clin Gastroenterol. 2011 Apr; 45(Suppl 1):S36-42.
  24. Buchner AM, Gomez V, Heckman MG, Shahid MW, Achem S, Gill KR, Jamil LH, Kahaleh M, Lo SK, Picco M, Riegert-Johnson D, Raimondo M, Sciemeca D, Wolfsen H, Woodward T, Wallace MB. The learning curve of in vivo probe-based confocal laser endomicroscopy for prediction of colorectal neoplasia. Gastrointest Endosc. 2011 Mar; 73(3):556-60.
    View PubMed
  25. Picco MF, Zubiaurre I, Adluni M, Cangemi JR, Shelton D. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease. Am J Gastroenterol. 2009 Nov; 104(11):2754-9. Epub 2009 Jul 07.
    View PubMed
  26. Cangemi JR, Picco MF. Intestinal ischemia in the elderly. Gastroenterol Clin North Am. 2009 Sep; 38(3):527-40.
    View PubMed
  27. Picco MF, Cangemi JR. Inflammatory bowel disease in the elderly. Gastroenterol Clin North Am. 2009 Sep; 38(3):447-62.
    View PubMed
  28. Edula RG, Picco MF. An evidence-based review of natalizumab therapy in the management of Crohn's disease. Ther Clin Risk Manag. 2009; 5:935-42
    View PubMed
  29. Isaacs KL, Sandler RS, Abreu M, Picco MF, Hanauer SB, Bickston SJ, Present D, Farraye FA, Wolf D, Sandborn WJ, Crohn's and Colitis Foundation of America Clinical Alliance. Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis. 2007 Oct; 13 (10):1250-5
    View PubMed
  30. Picco MF, Krishna M, Cangemi JR, Shelton D. Oral mesalamine and clinical remission are associated with a decrease in the extent of long-standing ulcerative colitis. Inflamm Bowel Dis. 2006 Jul; 12 (7):537-42
    View PubMed
  31. Sachar DB, Bodian CA, Goldstein ES, Present DH, Bayless TM, Picco M, van Hogezand RA, Annese V, Schneider J, Korelitz BI, Cosnes J, Task Force on Clinical Phenotyping of the IOIBD. Is perianal Crohn's disease associated with intestinal fistulization? Am J Gastroenterol. 2005 Jul; 100(7):1547-9.
    View PubMed
  32. Brant SR, Picco MF, Achkar JP, Bayless TM, Kane SV, Brzezinski A, Nouvet FJ, Bonen D, Karban A, Dassopoulos T, Karaliukas R, Beaty TH, Hanauer SB, Duerr RH, Cho JH. Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes. Inflamm Bowel Dis. 2003 Sep; 9(5):281-9.
    View PubMed
  33. Picco MF, Bayless TM. Tobacco consumption and disease duration are associated with fistulizing and stricturing behaviors in the first 8 years of Crohn's disease. Am J Gastroenterol. 2003 Feb; 98(2):363-8.
    View PubMed
  34. Scolapio JS, Picco MF, Tarrosa VB. Enteral versus parenteral nutrition: the patient's preference. JPEN J Parenter Enteral Nutr. 2002 Jul-Aug; 26: (4)248-50.
    View PubMed
  35. Lukens FJ, Loeb DS, Machicao VI, Achem SR, Picco MF. Colonoscopy in octogenarians: a prospective outpatient study. Am J Gastroenterol. 2002 Jul; 97(7):1722-5.
    View PubMed
  36. Picco MF. Crohn's disease: rational management. Consultant. 2002 Feb; 42(2):185-8, 191-4, 197.
  37. Picco MF. Crohn Disease: A rational approach to management. Drug Benefit Trends. 2002; 14(Suppl. A):25-33.
  38. Picco MF, Goodman S, Reed J, Bayless TM. Methodologic pitfalls in the determination of genetic anticipation: the case of Crohn disease. Ann Intern Med. 2001 Jun 19; 134 (12):1124-9
    View PubMed
  39. Picco MF. Ulcerative colitis: a rational approach to management. Consultant. 2001; 41(4):541-548.